drugset / Trial / NCT01110954

Fluorescence-guided Resection in Breast Cancer

NCT01110954 ↗

Phase 2 Terminated 8 enrolled photonamic GmbH & Co. KG
RandomizedParallel-groupTriple-blindDiagnostic

Summary

This is an explorative phase II study to investigate the suitability of PD L 506 in the specific intra-operative detection of breast tumour tissue.

Timeline

Start
2010-05-31
Primary completion
2012-07-19
Completion
2012-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject PD L 506 Diagnostic / imaging agent — —

Indications